170 related articles for article (PubMed ID: 34020830)
1. Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.
Mohamed ME; Gamal RM; El-Mokhtar MA; Hassan AT; Abozaid HSM; Ghandour AM; Abdelmoez A Ismail S; A Yousef H; H El-Hakeim E; S Makarem Y; Abdellatif Awad A
Hum Immunol; 2021 Sep; 82(9):634-639. PubMed ID: 34020830
[TBL] [Abstract][Full Text] [Related]
2. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
[TBL] [Abstract][Full Text] [Related]
4. Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of
Rao Muvva J; Parasa VR; Lerm M; Svensson M; Brighenti S
Front Immunol; 2019; 10():3157. PubMed ID: 32038652
[No Abstract] [Full Text] [Related]
5. Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype.
Ototake Y; Yamaguchi Y; Asami M; Komitsu N; Akita A; Watanabe T; Kanaoka M; Kurotaki D; Tamura T; Aihara M
J Invest Dermatol; 2021 Aug; 141(8):1954-1963. PubMed ID: 33705797
[TBL] [Abstract][Full Text] [Related]
6. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
Soldano S; Smith V; Montagna P; Gotelli E; Campitiello R; Pizzorni C; Paolino S; Sulli A; Cere A; Cutolo M
Arthritis Res Ther; 2024 Mar; 26(1):74. PubMed ID: 38509595
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.
Cutolo M; Soldano S; Gotelli E; Montagna P; Campitiello R; Paolino S; Pizzorni C; Sulli A; Smith V; Tardito S
Arthritis Res Ther; 2021 Dec; 23(1):306. PubMed ID: 34952630
[TBL] [Abstract][Full Text] [Related]
8. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
9. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
[TBL] [Abstract][Full Text] [Related]
10. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
Abumaree MH; Al Jumah MA; Kalionis B; Jawdat D; Al Khaldi A; Abomaray FM; Fatani AS; Chamley LW; Knawy BA
Stem Cell Rev Rep; 2013 Oct; 9(5):620-41. PubMed ID: 23812784
[TBL] [Abstract][Full Text] [Related]
11. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
12. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
[TBL] [Abstract][Full Text] [Related]
13. Periostin-An inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis.
Suzuki M; Ototake Y; Akita A; Asami M; Ikeda N; Watanabe T; Kanaoka M; Yamaguchi Y
PLoS One; 2023; 18(8):e0281881. PubMed ID: 37531393
[TBL] [Abstract][Full Text] [Related]
14. Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection.
Mily A; Kalsum S; Loreti MG; Rekha RS; Muvva JR; Lourda M; Brighenti S
J Vis Exp; 2020 Sep; (163):. PubMed ID: 33016941
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Monocyte and Macrophage Homeostasis in Periodontitis.
Almubarak A; Tanagala KKK; Papapanou PN; Lalla E; Momen-Heravi F
Front Immunol; 2020; 11():330. PubMed ID: 32210958
[TBL] [Abstract][Full Text] [Related]
16. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients.
Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB
BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885
[TBL] [Abstract][Full Text] [Related]
17. The cytokine language of monocytes and macrophages in systemic sclerosis.
Christmann RB; Lafyatis R
Arthritis Res Ther; 2010; 12(5):146. PubMed ID: 21067557
[TBL] [Abstract][Full Text] [Related]
18. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.
Nakano H; Kirino Y; Takeno M; Higashitani K; Nagai H; Yoshimi R; Yamaguchi Y; Kato I; Aoki I; Nakajima H
Arthritis Res Ther; 2018 Jun; 20(1):124. PubMed ID: 29895319
[TBL] [Abstract][Full Text] [Related]
19. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
20. Treatment with TNF-α inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation.
Lin SH; Chuang HY; Ho JC; Lee CH; Hsiao CC
J Dermatol Sci; 2018 Sep; 91(3):276-284. PubMed ID: 29914850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
